University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 15 of 29
Virtual Reality Treatment for Phantom Limb Pain
NCT03338842
Journey of Patients With Vasculitis From First Symptom to Diagnosis
NCT03410290
Social Incentives to Increase Mobility
NCT03321279
Real Time fMRI and Quitting Smoking
NCT03302026
Psoriatic Arthritis Research Collaborative: Biologic Sub-Study
NCT03378336
Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving
NCT03335735
Anti-Cytokine Therapy for Hemodialysis InflammatION
NCT03141983
Hypoglossal Nerve Stimulation on Cardiovascular Outcomes
NCT03359096
Rapid Pleurodesis Through an Indwelling Pleural Catheter
NCT03325192
Pulmonary Hypertension and Anastrozole Trial
NCT03229499
VCRC Longitudinal Protocol for Aortitis
NCT03022331
Cognitive Behavioral Therapy for Mechanical Ventilation Wean
NCT04763590
Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis
NCT03328585
Choice Architecture and Colorectal Cancer Screening Outreach
NCT03246438
Get Connected Efficacy Trial
NCT03132415
Effect of Galantamine on Inflammation and Cognition
NCT03384784
Social Incentives To Encourage Physical Activity and Understand Predictors
NCT03311230
Determining the Impact of Shunting and CerebroVascular Reactivity on 7T MRI (DISCoVeR 7T MRI)
NCT03291340
Telehealth Intervention in Cirrhotics
NCT03969186
Tailored Messaging for CRC Screening
NCT03310892
Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease
NCT03058679
Diet, Eating, and Lifestyle Improvement for Valued Employees and Their Relatives
NCT03277040
IMProving Executive Function Study
NCT03187353
CAR T Cell Immunotherapy for Pancreatic Cancer
NCT03323944
Legionnaires' Effect on Smell
NCT03321786
Restore Resilience in Critically Ill Children
NCT04695392
The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression
NCT03277846
Hybrid Closed Loop Insulin Delivery System in Hypoglycemia
NCT03215914
IN-TANDEM Familial Hypercholesterolemia Pilot Study
NCT03253432
Postoperative Virtual Clinical Encounters
NCT04138810
Mini Theta Burst TMS in MDD Patients
NCT04014959
Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women
NCT03209557
Reduced Radiation Dose and IR-impact on Coronary Calcium Quantification
NCT04267094
The Life STORRIED Study
NCT03134092
Transcranial Direct Current Stimulation for Primary Progressive Aphasia
NCT02928848
Mechanisms for Individual Differences in Hypertension in Obstructive Sleep
NCT03176732
Novel Neural Circuit Biomarkers of Major Depression Response to CCBT
NCT03096886
Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)
NCT03146741
Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers
NCT03038763
Evaluating Perceived Fitness to Drive While Intoxicated
NCT05028413
Behavioral Economic Incentives and Cancer Health Risk Assessment
NCT03068052
A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes (LUPE)
NCT03146754
Dendritic Cell Vaccination in Patients With Advanced Melanoma
NCT03092453
Stepping Up For Inflammatory Arthritis
NCT02912221
Vascular Inflammation in Psoriasis - Apremilast
NCT03082729
Accelerated TMS to a Novel Brain Target in MDD and PTSD
NCT03114891
Colorectal Cancer Screening in a Community Health Setting
NCT03072095
Music vs Midazolam During Preop Nerve Block Placement
NCT03069677
Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
NCT02911844
CAR T Cells in Mesothelin Expressing Cancers
NCT03054298
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.